At Goodland Pharma, our journey began with a profound passion for the triumphs of life science. Founded by visionaries deeply entrenched in the industry, we've cultivated global teams that have played pivotal roles in countless scientific breakthroughs. What sets us apart? Our seasoned expertise isn't just surface-level – it delves deep into your world, comprehending the intricate nuances of regulations and the critical factors that drive clinical trial success. Get started here: https://lnkd.in/g_z8FmWD #GoodlandPharma #TailoredSolutions #LifeScience #ClinicalTrials
Goodland Pharma’s Post
More Relevant Posts
-
🌟 🚀 Stay Tuned for our big announcement in the coming weeks as we're set out to support the digital transformation of Pharma and life science industry! Exciting news coming up! 🙌 #pharmadigitaltransformation
-
-
In early to mid-stage biotech, you’re often juggling multiple responsibilities -- managing clinical trials can be just one of many responsibilities. In this video clip from our event earlier this summer, Divya Chadha Manek OBE discusses the challenges that come with wearing many hats. It helps emphasize why it’s essential to have the right partners and support in place to ensure trial success. Missed the event? Watch the full on-demand videos to explore strategies for managing clinical trials more effectively and discover how Yourway can help simplify the process. https://lnkd.in/gTTm6ZrY #Biotech #ClinicalTrials #PharmaLogistics #DublinDepot #DrugDiscovery #Partner
-
Well said. It’s simple…. What are your pain points, let’s talk
We provide extensive experience in industrial medicines discovery and informatics combined with access to innovative technologies, platforms, and outsourced, multiparty R&D.
What does the Medicines Discovery Catapult do? A question I am often asked, and I could answer by saying: - "We support drug discovery innovators by providing world-leading scientific and drug discovery expertise, state-of-the-art laboratory facilities and infrastructure, with advanced technologies and analytics." or "We accelerate innovation, support business growth, and help improve patient outcomes." But I like to keep things simple, and I usually explain that we are here to fill in the gaps. Would you like to talk about how? #drugdiscovery #biomarkers
-
⏳ The countdown is on for Wilson Sonsini’s Inaugural Biotech Summit in Boston, October 9-10! ⌛ HIC's CEO and Principal Regulatory Advisor, Deb Autor, will share insights on FDA hot topics and regulatory trends alongside fellow industry leaders. Why attend? 👥 Connect with influential and knowledgeable leaders at the intersection of biotech, venture capital, and policy. ✍ Learn about regulatory trends, antitrust issues, and strategic collaborations that drive innovation in medical therapies. 🗣 Engage in topics that will highlight ways to leverage AI in healthcare. You don't want to miss this event! #BiotechSummit #FDA #Biotech #Boston #WilsonSonsini #Innovation #MedTech #PharmaBiotech #Regulatory
-
-
We provide extensive experience in industrial medicines discovery and informatics combined with access to innovative technologies, platforms, and outsourced, multiparty R&D.
What does the Medicines Discovery Catapult do? A question I am often asked, and I could answer by saying: - "We support drug discovery innovators by providing world-leading scientific and drug discovery expertise, state-of-the-art laboratory facilities and infrastructure, with advanced technologies and analytics." or "We accelerate innovation, support business growth, and help improve patient outcomes." But I like to keep things simple, and I usually explain that we are here to fill in the gaps. Would you like to talk about how? #drugdiscovery #biomarkers
-
💡 Breaking New Ground in Biopharma: ReSync Bio Raises Fresh Funding 💡 ReSync Bio, a San Francisco-based scientific software company, has secured new funding from Caffeinated Capital, Atria Ventures, and angel investors like Ramsey Homsany (co-founder of Octant Bio)! 💰 🔬 What does ReSync Bio do? Led by CEO Mihir Trivedi, ReSync Bio provides a SaaS platform designed to accelerate drug discovery for biopharma companies. By serving as a single source for preclinical data, the platform automates coordination between labs and CROs, allowing teams to bring drugs to the clinic more efficiently. 💊 🔑 Key features include: • Controlled data permissioning to protect IP 🔒 • Enhanced collaboration across in-house and external teams 🤝 • Streamlined R&D operations from labs to clinics 🧬 This new funding will support key hires and the commercialization of their platform, which is now available for companies and academics! 💻 The future of drug discovery is faster, smarter, and more connected with ReSync Bio. 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #Biopharma #DrugDiscovery #SaaS #R&D #Innovation #PreclinicalResearch #FutureTechly
-
-
People often ask me what the hardest thing about scaling is, particularly as we build our team out globally. In my experience, it’s judgement. Having the people alongside you who you can trust to take the right decisions 99% of the time and only involve you the 1% where they might need to. So you can imagine how delighted I am to be working alongside Andrea Sotak as we build and scale Weatherden in North America. It’s going to be great, and it’s going to be fun. #disruptingdrugdevelopment #thinkfirst #optimisestrategy #taketherightrisk
We are delighted to announce another major hire with Andrea Sotak joining us as Head of Strategy and SVP Corporate Development. Andrea has spent her career focused on therapeutics as an investor and is a strategically minded senior executive and business operations leader. She brings an exemplary 20+ year track record of assessing what an asset is worth, and a detailed understanding of what drives value in biopharma. Andrea has worked across all modalities, therapeutic areas, and stages of clinical development. As part of the Weatherden team, she will lead our Strategy division in working with clients to build the bridge between scientific and commercial thinking, supporting value creation and helping to ensure that there is a clear communication of value to stakeholders across the drug development lifecycle. As Weatherden continues to grow we will benefit from Andrea’s experience scaling teams and organizations. Her addition to the team also strengthens our North American presence. Please join us in welcoming Andrea, we are excited to have you on board! #NewHire #DrugDevelopment #DrugDiscovery #TranslationalMedicine #AI #ClinicalDevelopment #Pharma #Biotech #Techbio
-
-
CTO & Co-Founder of Infopoly Limited | Digital Innovation | Data Infrastructure & Analytics | Web Development | From Monday Chaos to Clarity
🌟 Celebrating Innovation and Teamwork! 🌟 Thrilled to share a major milestone achieved by the Infopoly team. Our collaboration with eptivA Therapeutics Ltd. has resulted in a 20x reduction in analysis times through advanced cloud solutions. By automating their network biology algorithm, eptivA Therapeutics Ltd. has launched Pain Cloud®—a pioneering B2B platform for precision pain management. This success highlights how cloud computing, fuelled by strong partnerships, is transforming biotech, pharma, and life sciences. Reflecting on Our Journey: It's been incredibly rewarding working with such talented individuals at Infopoly and our innovative partners. Together, we're making meaningful strides in technology and human health. Join the Conversation: 🗣️ What challenges have you faced in your R&D process? Share your thoughts in the comments! For more details, check out the original post in the comments 👇🏼. #CloudComputing #Biotech #Innovation #HealthcareIT #InfopolyTech #DigitalTransformation #Pharma #LifeSciences #TechInnovation #ResearchAndDevelopment
-
‘Navigating the Biopharma Services Lanscape: Current Trends and Future Perspectives’ at BIO-Europe - interesting discussions regarding price vs value in service providers. Speed, flexibility, dependability and quality are key considerations when delivering novel molecules to the clinic, not just cost, and a track record of delivering success commands a premium Sygnature Discovery #BioEurope
-
-
In the fast-paced life sciences industry, fostering global team effectiveness, implementing best practices, and navigating change are more critical than ever. At the American Pharma & Biotech Conference in San Francisco, Pankit Bhalodia from West Monroe shared his insights on these very topics. Key takeaways included: 🌎 Global Team Effectiveness: Strategies for fostering collaboration across diverse, international teams. 🔑 Best Practices: How to quickly develop and implement practices that are not just theoretical but truly actionable. 💡Innovation and Change: Guiding teams through the complexities of change and fostering a culture of innovation. For a deeper dive into these themes, explore our POV on Rethinking Traditional Operating Models in Life Sciences: https://lnkd.in/giSWA32g #PharmaInnovation #PharmaConference #Biotech #Events #GlobalTeams
-
